The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
International Castleman's Disease Organization
4 Brazos Court
Santa Fe, NM 87508
The International Castleman's Disease Organization (ICDO) is a voluntary organization whose mission is to provide research information, clinical points of contact, and cancer treatment facilities to patients of Castleman's disease and the patients' families. Castleman's disease is characterized by a single, solid growth within lymphatic tissue in the chest, stomach, or neck. Growths may also occur in other lymphatic tissue throughout the body. Usually the growths represent abnormal enlargement of the lymph nodes (lymphoid hamartoma) normally found in these areas. There are three types of Castleman's disease: hyaline-vascular type; plasma cell type; and a third type that affects more than one area of the body (generalized or multicentric Castleman's) has been also been identified.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.